Overview
SARS-CoV (severe acute respiratory syndrome coronavirus) is the zoonotic, positive-sense single-stranded RNA coronavirus that caused the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002–2003. Transmitted to humans from animal reservoirs, it is a member of the family Coronaviridae and displays the distinctive crown-like fringe of spike (S) glycoprotein projections common to coronaviruses. SARS-CoV is historically significant both as the first coronavirus to cause a major international epidemic of severe respiratory disease and as a close phylogenetic relative of SARS-CoV-2, the agent of COVID-19, making it an important reference point for comparative virology. Study of SARS-CoV centres on its genome organization, evolutionary relationships to other human and animal coronaviruses, the structure and function of its spike protein in mediating host-cell entry, and its mechanisms of pathogenesis. Comparative analyses of spike glycoprotein-coding gene sequences illuminate how SARS-CoV relates to SARS-CoV-2 and to animal coronaviruses, informing understanding of cross-species transmission and emergence. Research published under this topic examines viral evolution, transmissibility, immune responses, neutralizing antibodies, candidate therapeutics, and the broader lessons that the original SARS epidemic offers for surveillance of and preparedness against emerging coronavirus threats.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
SARS-CoV-2 affected cells Pathogeny and Therapy
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
An Algorithm to Predict the Possible SARS-CoV-2 Mutations
Analytical Solutions of the Transmissibility of the SARS-CoV-2 in Three Interactive Populations
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
How this research is being cited
The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
2023 · Research Square (Research Square)
-
2023 · Journal of Model Based Research
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Journal of Model Based Research
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Applied Mathematics and Nonlinear Sciences
A sample of recent works citing this journal's research on SARS-CoV, linking to each citing work.